Treatments of hemispatial neglect with CNS modulators

Treatments of hemispatial neglect with CNS modulators - treatment of hemispatial neglect

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004872

Enrollment

Registered

2011-04-01

Start date

2012-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemispatial neglect due to cerebrovascular accidents

Interventions

HSN. 1st. donepezil, 2nd placebo HSN. 1st placebo, 2nd donepezil healthy control. 1st. donepezil, 2nd placebo healthy control. 1st placebo, 2nd donepezil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients of hemispatial neglect at least 1 month after the onset of cerebrovascular accident. Age-matched healthy volunteer

Exclusion criteria

Exclusion criteria: Those who present apparent aphasia or dementia. Patients with history of epilepsy.

Design outcomes

Primary

Measure	Time frame
Behavioral performance on a PC-based visual detection task	—

Countries

Japan

Contacts

Public ContactShunsuke Kobayashi

Fukushima Medical University Department of Neurology

skoba-tky@umin.net024-547-1248

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026